Navigation Links
Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
Date:9/18/2007

Z-004 in 129 schizophrenic patients with acute agitation. In that trial, the 10 mg dose of AZ-004 met the primary endpoint of the clinical trial, showing a statistically significant (p < 0.05) reduction in agitation compared to placebo. The primary endpoint in the trial was the change in the PANSS (Positive and Negative Symptom Scale) Excited Component (PEC) score at the 2-hour post-dose time point.

PEC Scores (Mean Values)

p-value

Study Arm Baseline 2-hour Post-Dose vs. placebo

10 mg AZ-004 17.3 8.8 0.0001

5 mg AZ-004 17.6 10.8 0.088

Placebo 17.7 12.7 -

The 10 mg dose of AZ-004 also exhibited a rapid onset of effect. At 20 minutes post-dose, the 10 mg dose showed statistically significant improvement in the PEC score, compared to placebo. The effectiveness of the 10 mg dose was sustained throughout the 24-hour study period, compared to placebo.

Using the Behavioral Activity Rating Scale (BARS), the 10 mg dose of AZ-004 showed statistically significant improvement, compared to placebo, beginning at 30 minutes. This response was sustained throughout the 24-hour study period, compared to placebo.

Clinical Global Impression-Severity (CGI-S) scale ratings to measure agitation were completed at baseline, immediately prior to AZ-004 administration. At the 2-hour post-dose time point, a Clinical Global Impression-Improvement (CGI-I) evaluation was completed for each patient. Both the 10 mg and the 5 mg doses of AZ-004 showed statistically significant improvements in the CGI-I scale, compared to placebo.

Side effects were recorded throughout the clinical trial period. The administration of AZ-004 was generally safe and well tolerated. The most common side effects reported were taste, sedation and dizzines
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. A smoke free place to be initiated
2. Stem Cell Treatment For Children With Brain Injury To Be Initiated
3. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
4. Massive Production Of Bird Flu Vaccine To Be Initiated In China
5. Exclusive Team initiated To Check Bird Flu Pandemic: Jakarta
6. Chugai Pharmaceutical To Initiate Domestic Production Of Bird Flu Vaccine
7. Bird Flu: Orissa Initiates Protective Measures
8. Biota Initiates Drug Testing War against Common Cold
9. HIV/AIDS Vaccine Trial To Be Initiated Soon
10. Large Scale Multiple Sclerosis Vaccine Trial to Be Initiated By PharmaFrontiers
11. Russia Initiates Mass Vaccination Of Poultry To Restrict Bird Flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... In ... help with the problems of substance abuse that face today’s society, A Forever ... to come to their rehabilitation center. The facility, located in Southwest Michigan hosted ...
(Date:7/29/2015)... ... July 29, 2015 , ... This past week, CARE Surrogacy Center ... a treasured member of the CARE extended family. , By shedding light on ... parents across the globe gain a newfound perspective on surrogacy in Mexico. The center ...
(Date:7/29/2015)... ... July 29, 2015 , ... Abt Associates has named Selena ... division. In her position, Ramkeesoon will help build and expand work in ... spent close to a decade at ICF International, most recently as a vice ...
(Date:7/29/2015)... Boston, MA (PRWEB) , ... July 29, 2015 ... ... nonconforming experience widespread discrimination and health inequities. Since 2012, Massachusetts law has provided ... public education, and business. However, the law does not protect against discrimination based ...
(Date:7/29/2015)... , ... July 29, 2015 , ... " Core Organizer ... look at the latest and coolest applications on the market for iOS, Android, and ... and shared with viewers how this app will help anyone get organized. , Wouldn’t ...
Breaking Medicine News(10 mins):Health News:MADD Victim Services Specialist Visits A Forever Recovery Rehabilitation Facility 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Get More Organized with the Core Organizer App 2
... improved planning of care and stronger relationships with physicians ... to a study by a Queen,s University professor. , ... every Canadian," says professor of Medicine and Epidemiology Daren ... Hospital. "But it,s not always happening. We know from ...
... WEDNESDAY, Oct. 27 (HealthDay News) --Mental health issues confronted ... Iraq and Afghanistan differ by gender, new research suggests. ... a diagnosis of depression than are their male counterparts, ... received health care from the Veterans Administration from 2002 ...
... Heidelberg, Germany, 27 October 2010 The European ... of outstanding research contributions by 63 life scientists ... life-long honour of EMBO membership, joining almost 1500 ... Members are the basis for the organization,s international ...
... a portable scanner based on radio frequency technology, which is able ... and benign in the breast on a computer. , Using ... proven by researchers in the US, Canada and UK. However, up ... to be produced, and this had to be done in a ...
... awarded six grants totaling approximately $12 million over ... fostering a diverse scientific workforce. The initiative, called ... Promote Diversity in the Scientific Workforce, is funded ... and administered by NIH,s National Institute of General ...
... News) -- Older adults who survive severe sepsis are at ... functioning, a new study indicates. This largely invisible problem ... burden on caregivers and families, as well as increasing the ... said. Also called "blood poisoning," sepsis is a potentially ...
Cached Medicine News:Health News:Mental Health Issues Differ for U.S. Male, Female Vets 2Health News:EMBO recognizes 63 researchers for advances in life sciences 2Health News:EMBO recognizes 63 researchers for advances in life sciences 3Health News:Portable breast scanner allows cancer detection in the blink of an eye 2Health News:NIH Recovery Act grants to foster scientific workforce diversity 2Health News:Brain Deficits Higher in Seniors Who Survive Blood Poisoning 2
(Date:7/29/2015)... CAMBRIDGE, Mass. , July 29, ... ), the leader in RNA-targeted therapeutics, and Akcea ... The New England Journal of Medicine ... study evaluating volanesorsen (formerly ISIS-APOCIII Rx ) in ... This publication follows the December 2014 publication in ...
(Date:7/29/2015)...  Hologic, Inc. (NASDAQ: HOLX ) announced today ... ended June 27, 2015.  Quarterly revenues of $693.9 million ... a constant currency basis.  GAAP earnings per share (EPS) ... increased 16.2%. "Our third quarter financial results ... a company that can grow sustainably on both the ...
(Date:7/29/2015)... Inc. (Vanda) (NASDAQ: VNDA ), today announced financial ... 30, 2015. "We are impressed with U.S. ... H. Polymeropoulos M.D., Vanda,s President and CEO, "further investments ... products set the stage for the next level of ... , Total net product sales for the second quarter ...
Breaking Medicine Technology:Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 2Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 3Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 4Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 5Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 6Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 7Hologic Announces Financial Results for Third Quarter of Fiscal 2015 2Hologic Announces Financial Results for Third Quarter of Fiscal 2015 3Hologic Announces Financial Results for Third Quarter of Fiscal 2015 4Hologic Announces Financial Results for Third Quarter of Fiscal 2015 5Hologic Announces Financial Results for Third Quarter of Fiscal 2015 6Hologic Announces Financial Results for Third Quarter of Fiscal 2015 7Hologic Announces Financial Results for Third Quarter of Fiscal 2015 8Hologic Announces Financial Results for Third Quarter of Fiscal 2015 9Hologic Announces Financial Results for Third Quarter of Fiscal 2015 10Hologic Announces Financial Results for Third Quarter of Fiscal 2015 11Hologic Announces Financial Results for Third Quarter of Fiscal 2015 12Hologic Announces Financial Results for Third Quarter of Fiscal 2015 13Hologic Announces Financial Results for Third Quarter of Fiscal 2015 14Hologic Announces Financial Results for Third Quarter of Fiscal 2015 15Hologic Announces Financial Results for Third Quarter of Fiscal 2015 16Hologic Announces Financial Results for Third Quarter of Fiscal 2015 17Hologic Announces Financial Results for Third Quarter of Fiscal 2015 18Hologic Announces Financial Results for Third Quarter of Fiscal 2015 19Hologic Announces Financial Results for Third Quarter of Fiscal 2015 20Hologic Announces Financial Results for Third Quarter of Fiscal 2015 21Hologic Announces Financial Results for Third Quarter of Fiscal 2015 22Hologic Announces Financial Results for Third Quarter of Fiscal 2015 23Hologic Announces Financial Results for Third Quarter of Fiscal 2015 24Hologic Announces Financial Results for Third Quarter of Fiscal 2015 25Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 6
... Feb. 22, 2011 Proacta Incorporated and ... announced the execution of a definitive agreement ... commercialization of Proacta,s PR509, a hypoxia-activated pro-drug ... (Logo: http://photos.prnewswire.com/prnh/20110222/LA50556LOGO-a) (Logo: http://photos.prnewswire.com/prnh/20110222/LA50556LOGO-b) ...
... ResearchDx announced today the official launch of ... Recent FDA initiatives, such as the ... Paper, have spurred biopharmaceutical companies, interest in biomarker ... The traditional Contract Research Organization (CRO), which has ...
Cached Medicine Technology:Proacta Incorporated and Yakult Honsha Announce an Agreement for the Collaborative Research, Development and Commercialization for Proacta's PR509 Compound 2Proacta Incorporated and Yakult Honsha Announce an Agreement for the Collaborative Research, Development and Commercialization for Proacta's PR509 Compound 3ResearchDx Launches Contract Diagnostics Organization (CDO) 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: